![Nadia Harbeck](/var/esmo/storage/images/media/esmo-daily-reporter/images/portraits/nadia-harbeck/19125217-1-eng-GB/nadia-harbeck_i770.jpg)
Making personalised precision medicine a reality for early breast cancer
Individualised assessment of initial response to therapy may pave the way for chemotherapy-sparing treatment, but it requires that multidisciplinary teams adapt their current practices